In the schedule below, click on a session title to go to that particular session. Keynote talks are designated with an asterisk. Abstracts of the talks and posters have been posted here beginning November 6,
2011.
SUNDAY,
NOVEMBER 6
Session 1: Introduction and Overviews
Session
1: (Chair,
John Coffin)
John Coffin Welcoming Remarks
*
Raymond Schinazi The Drug Development Process: The Case of Hepatitis C Virus
(Abstract)
*
Charles Bangham
HTLV-1 Persistence in Vivo: Clonality, Dynamics and Immune Response
(Abstract)
MONDAY,
NOVEMBER 7
Session
2: Viral Entry Session
2: (Chair,
Jonathan Stoye)
* Billy Tsai How the Non-Enveloped SV40 Penetrates the ER Membrane during Entry
(Abstract)
* Walther Mothes Cell-to-Cell Transmission Can Overcome Multiple Barriers Imposed on Cell-Free HIV
(Abstract)
Javier G. Magadán Transmembrane Domain Determinants of CD4 Downregulation by HIV-1 Vpu
(Abstract)
Session
3: Nucleic Acid Replication Session
3: (Co-Chairs, Kenneth Johnson and Harriet Isom)
* Timothy Tellinghuisen The Hepatitis C Virus NS5A Protein: Emerging Roles in Replication, Assembly, and Regulation Define a Potent Antiviral Target
(Abstract)
Katarzyna Purzycka Making Sense of Antisense: Exploring RNA Structure within TY1 Virus-Like Particles
(Abstract)
Kalyan Das Crystal Structure of HIV-1 Reverse Transcriptase in Complex with dsDNA and Nevirapine Reveals Non-Nucleoside Inhibitor Mechanism
(Abstract)
Wei Yang
Novel Insights from the High Resolution Structure of HIV-1 RT Containing a Nonnucleoside Inhibitor and an RNA/DNA Hybrid
(Abstract)
Atsuko Hachiya HIV-1 Reverse Transcriptase (RT) Polymorphism 172K Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Nonnucleoside RT Inhibitors
(Abstract)
Daouda Abba-Moussa Structural Dynamic of HIV-1 Reverse Transcriptase as a New Target to Block HIV Replication
(Abstract)
* Peter Cherepanov The Mechanism of HIV Integration and Its Inhibition by Strand Transfer Inhibitors: Lessons from X-ray Crystallography Studies Using a Convenient Model System
(Abstract)
Kasthuraiah Maddali Dihydroxy-oxoisoindoline Derivatives That Target Raltegravir-Resistant HIV-1 Integrase: A Novel Approach
against HIV/AIDS
(Abstract)
Barry Johnson Applying MD Simulations to an HIV-1 Integrase Model (Abstract)
Session
4: Host Factors in Viral Replication Session
4: (Chair,
Henry Levin) * Jeremy Luban TRIM5 Is an Innate Immune Sensor for the Capsid of HIV-1 and Other Retroviruses
(Abstract)
* Monsef Benkirane How SAMHD1 May Change Our View of Viral Restriction (Abstract)
Jonathan Stoye Structure and Function of the HIV Restriction Factor SAMHD1
(Abstract)
KyeongEun Lee Interplay between CPSF6 and TNPO3 Regulates HIV-1 Early Infection
(Abstract)
Leslie Parent CRM1 and the Viral RNA Packaging Element Promote Plasma Membrane Localization of the Rous Sarcoma Virus Gag Protein
(Abstract)
Xiaofei Jia Structural Basis of HIV-1 Nef-Mediated Downregulation of MHC-I
(Abstract)
Poster
Session 1
TUESDAY,
NOVEMBER 8
Session
5: Biology of Viral Infection Session
5: (Chair,
Jeffrey Lifson) * Marco Salemi Phylogeography of Human Infectious Diseases (Abstract)
Dara Lehman Low-Frequency Nevirapine Resistance at Multiple Sites May Predict Treatment Failure in Infants on Nevirapine-Based Treatment
(Abstract)
Gisela Heidecker Evolution of the Primate APOBEC3 Locus (Abstract)
* Eric Delwart Drinking from the Metagenomic Fire Hose: Viral Discovery through Sequence Homology
(Abstract)
Krista Delviks-Frankenberry The Genesis of XMRV through Recombination (Abstract)
Mary Kearney
Multiple Sources of Contamination in Samples from Patients Reported to Have XMRV Infection
(Abstract)
Session
6: Novel Antiviral Strategies
Session
6: (Chair,
Ronald Swanstrom)
* Robert Siliciano A Quantitative Basis for HAART (Abstract)
Lori Emert-Sedlak Identification of Small Molecule Inhibitors of HIV-1 Nef Function via Src-Family Kinase Coupling in Vitro Identifies a Novel Inhibitor of HIV-1 and SIV Replication
(Abstract)
Marc Potempa Processing Site Context Contributes to Determining the Rate of HIV-1 Protease-Mediated Processing of Gag
(Abstract)
Kayoko Waki A Tale of Two HIV-1 Maturation Inhibitors — Bevirimat (BVM) and PF-46396: Insights into Gag Assembly and Virion Maturation
(Abstract)
* Paula Cannon Designer Nucleases as Antiviral Therapies
(Abstract)
Session
7: Microbicides and Other Preventive Strategies
Session
7: (Chair,
Brandon Keele)
* Ian McGowan Antiretrovirals for HIV Prevention (Abstract)
Mayla Hsu The Selection of MIV-150 Resistance-Associated Mutations in SHIV-RT-Infected Rhesus Macaques
(Abstract)
* Walid Heneine Monkey Models of Antiretroviral Prophylaxis for HIV Prevention
(Abstract)
Poster
Session 2
WEDNESDAY,
NOVEMBER 9
Session 8: Assembly, Release, and Processing
Session
8: (Chair,
Rebecca Craven) * Michael Malim Using Rodent Cells to Study HIV-1 Assembly (Abstract)
Olga Nikolaitchik Regulation of HIV-1 RNA Packaging
(Abstract)
* Angela Gronenborn Structures of Vpr and Vpx in DDB1-DCAF1 Complexes — Unique Surfaces for Substrate Recruitment (Abstract)
* Akira Ono Localization of HIV-1 Gag to the Plasma Membrane and Its Subdomain (Abstract)
Alan Rein HIV-1 and MLV Particle Assembly: There Are Many Ways to Get Together
(Abstract)
Lichun Li A Phase Diagram Describing the Mechanism of HBV Core Protein Assembly Effectors
(Abstract)
* Bogdan Dragnea Templated Assembly and Photothermal Imaging of HIV-1 Gag Virus-Like Particles
(Abstract)
*
Owen Pornillos Structural and Biochemical Analyses of HIV-1 Capsid Assembly and Maturation
(Abstract)
Stephen Hughes Closing Remarks
Home Welcome
| General
Information | Registration
| Abstract
Submission | Important
Dates Invited
Speakers | Scientific
Program | Participation
Support | Sponsors
| Contact
|